DIPG is a death sentence for children today, but it doesn’t have to be; this resolution is an important first step in securing the resources needed to develop better treatment options and find a cure.Congresswoman Jackie Speier (D-CA-14), leading sponsor of the DIPG Awareness Resolution
Posted by the PNOC Foundation
In support of H. Res 114 – the DIPG Awareness Resolution, experts from around the world will testify in a briefing to members of Congress and their staff at 11am on Thursday, Feb. 13 in the Gold Room of the Rayburn House Office Building in Washington, DC.
The panel includes PNOC Project Leader Dr. Sabine Mueller who is the Director of DIPG Centre of Excellence, University Children’s Hospital Zurich; and PNOC Scientific Chair Dr. Adam Resnick, Director of Data Driven Discovery in Biomedicine, Children’s Hospital of Philadelphia (CHOP) Scientific Chair, Children’s Brain Tumor Tissue Consortium (CBTTC), as well as Dr. Charles Keller, Scientific Director, Children’s Cancer Therapy Development Institute (cc-TDI), Beaverton, OR NCI/COG Soft Tissue Sarcoma (STS) Committee; Josh Allen, Ph.D., Senior Vice President, Oncoceutics; 2016 Forbes “30 Under 30” and inventor of ONC201, and David Arons CEO, National Brain Tumor Society.
Read about it here: http://ow.ly/oeox50ycBq0